Sotera Health (NASDAQ:SHC) Director Sells $193,194,516.17 in Stock

Posted by Stanley Muller on May 15th, 2026

Sotera Health Company (NASDAQ:SHC – Get Free Report) Director Gtcr Investment Xi Llc sold 12,735,301 shares of the firm’s stock in a transaction that occurred on Wednesday, May 13th. The shares were sold at an average price of $15.17, for a total transaction of $193,194,516.17. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website.

Gtcr Investment Xi Llc also recently made the following trade(s):

On Friday, March 6th, Gtcr Investment Xi Llc sold 10,000,000 shares of Sotera Health stock. The shares were sold at an average price of $15.27, for a total transaction of $152,700,000.00.

Sotera Health Stock Down 1.4%

SHC traded down $0.22 during trading on Friday, hitting $15.27. The stock had a trading volume of 6,857,875 shares, compared to its average volume of 2,909,578. The stock has a 50 day simple moving average of $14.89 and a two-hundred day simple moving average of $16.44. The company has a market capitalization of $4.35 billion, a PE ratio of 37.24 and a beta of 1.82. Sotera Health Company has a twelve month low of $10.80 and a twelve month high of $19.85. The company has a debt-to-equity ratio of 3.56, a quick ratio of 2.54 and a current ratio of 2.82.

Sotera Health (NASDAQ:SHC – Get Free Report) last posted its quarterly earnings results on Tuesday, May 5th. The company reported $0.18 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.17 by $0.01. The business had revenue of $280.05 million during the quarter, compared to analysts’ expectations of $270.78 million. Sotera Health had a net margin of 9.91% and a return on equity of 39.73%. The business’s quarterly revenue was up 10.0% on a year-over-year basis. During the same quarter last year, the company posted $0.14 earnings per share. Sotera Health has set its FY 2026 guidance at 0.930-1.010 EPS. On average, research analysts predict that Sotera Health Company will post 0.86 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in SHC. Empowered Funds LLC raised its holdings in shares of Sotera Health by 11.1% during the first quarter. Empowered Funds LLC now owns 28,512 shares of the company’s stock worth $332,000 after purchasing an additional 2,845 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Sotera Health by 14.5% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 342,934 shares of the company’s stock worth $3,999,000 after purchasing an additional 43,471 shares during the last quarter. Acadian Asset Management LLC raised its holdings in shares of Sotera Health by 125.5% during the first quarter. Acadian Asset Management LLC now owns 25,192 shares of the company’s stock worth $293,000 after purchasing an additional 14,018 shares during the last quarter. Creative Planning raised its holdings in shares of Sotera Health by 15.3% during the second quarter. Creative Planning now owns 20,186 shares of the company’s stock worth $224,000 after purchasing an additional 2,673 shares during the last quarter. Finally, Invesco Ltd. raised its holdings in shares of Sotera Health by 4.2% during the second quarter. Invesco Ltd. now owns 319,156 shares of the company’s stock worth $3,549,000 after purchasing an additional 12,758 shares during the last quarter. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on SHC. Wall Street Zen cut shares of Sotera Health from a “strong-buy” rating to a “buy” rating in a report on Saturday, April 11th. Barclays decreased their price target on shares of Sotera Health from $20.00 to $18.00 and set an “overweight” rating for the company in a report on Tuesday, April 14th. Piper Sandler reaffirmed an “overweight” rating and issued a $22.00 price target (down from $24.00) on shares of Sotera Health in a report on Wednesday, May 6th. Citigroup raised their target price on shares of Sotera Health from $21.00 to $23.00 and gave the stock a “buy” rating in a report on Tuesday, February 24th. Finally, Zacks Research cut shares of Sotera Health from a “strong-buy” rating to a “hold” rating in a report on Friday, January 30th. Seven research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat.com, Sotera Health currently has a consensus rating of “Moderate Buy” and an average target price of $20.33.

Get Our Latest Stock Report on SHC

Sotera Health Company Profile

(Get Free Report)

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.

Insider Buying and Selling by Quarter for Sotera Health (NASDAQ:SHC)

Receive News & Ratings for Sotera Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sotera Health and related companies with MarketBeat.com's FREE daily email newsletter.